Methylphenidate Treatment of Cancer-Related Fatigue

NCT00758407 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer-related Fatigue

Interventions

DRUG: Methylphenidate hydrochloride
DRUG: Placebo

Sponsor

Medice Arzneimittel Pütter GmbH & Co KG